Skip to main content
. 2020 Apr 18;21(8):2825. doi: 10.3390/ijms21082825

Figure 2.

Figure 2

Effects of an AKT inhibitor (AZD5363) and mTOR inhibitors (AZD2014 and BEZ235) on the proliferation of mTOR-mutated or wild-type bladder cancer cells. (A) Molecular characteristics of J82 and 253J-BV cell lines. (B) Effects of AZD5363, AZD2014, and BEZ235 on J82 and 253J-BV cells were determined using CellTiter Glo. The results are presented as the mean ± SD of triplicate wells and are representative of three independent experiments.